The Claim
Non-acetate zinc lozenges administered at doses exceeding 75 mg/day reduce the duration of colds by an average of 20%, with significant heterogeneity observed across five clinical trials, indicating that efficacy may depend on the specific formulation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking certain zinc lozenges (not the acetate kind) in high daily doses might shorten how long you have a cold by about one-fifth, but different brands or types seem to work differently based on studies.
See the scientific wording
Non-acetate zinc lozenges with doses over 75 mg/day reduce cold duration by 20% on average but show significant heterogeneity in effects across five trials, suggesting formulation-dependent efficacy.
What the research says
1 studyStudy: Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review
The study found that zinc lozenges with over 75 mg/day of non-acetate zinc reduced colds by about 20%, just like the claim says, and it also showed that different types of zinc lozenges work differently.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.